Concepedia

Virginia E. Kwitkowski

VE

16

Publications

1.6K

Citations

16

H-Index

2006

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Institutes of Health

National Cancer Institute

Center for Cancer Research

Virginia E. Kwitkowski is an author at United States Food and Drug Administration specializing in medicine, immunology, and pharmacotherapy.

Top concepts

Publications per year

2006–2020

16

Publications

16

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski et al. · Journal of Clinical Oncology · 2008 · 336 citations · Full text

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

Virginia E. Kwitkowski, Tatiana M. Prowell, Amna Ibrahim et al. · The Oncologist · 2010 · 240 citations · Full text

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Angelo de Claro, Karen M. McGinn, Virginia E. Kwitkowski et al. · Clinical Cancer Research · 2012 · 207 citations

, , +12

PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Charles S. Cleeland et al. · Value in Health · 2010 · 163 citations

, , +6

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

Edwin M. Posadas, Meghan S. Liel, Virginia E. Kwitkowski et al. · Cancer · 2007 · 143 citations · Full text

Rows per page

1–5 of 16